Compugen (CGEN)
US$ 1.78-1.66%
Price Chart
Key Statistics
Market Cap
$ 142.14M
P/E Ratio
0.00
Revenue (TTM)
$ 27.86M
Volume
212.22K
52W High
$ 2.66
52W Low
$ 1.13
Dividend Yield
0.00%
Beta
3.20
Technicals
50-Day MA
1.5714
200-Day MA
1.7569
52 Week High
2.66
52 Week Low
1.13
About CGEN
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United .
Employees
74
Headquarters
Holon, Israel
CEO
Dr. Anat Cohen-Dayag Ph.D.
Latest News
Is There An Opportunity With Compugen Ltd.'s (NASDAQ:CGEN) 33% Undervaluation? - simplywall.st
4 weeks ago • Google News
Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan
2025-03-26 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg